What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Cancer
His primary areas of study are Internal medicine, Gastroenterology, Surgery, Hepatocellular carcinoma and Cirrhosis. The Internal medicine study combines topics in areas such as Endocrinology, Immunology and Hepatitis B virus. His Endocrinology research includes themes of Acute pancreatitis and Pancreatitis.
His Gastroenterology study combines topics in areas such as Survival rate, Predictive value of tests, Hepatitis, Proportional hazards model and Model for End-Stage Liver Disease. His work in Hepatocellular carcinoma addresses issues such as Carcinoma, which are connected to fields such as Liver cancer, Survival analysis and Retrospective cohort study. His work deals with themes such as Liver disease and Ascites, which intersect with Cirrhosis.
His most cited work include:
- Genetic Diversity of Hepatitis B Virus Strains Derived Worldwide: Genotypes, Subgenotypes, and HBsAg Subtypes (740 citations)
- Des-γ-Carboxy (Abnormal) Prothrombin as a Serum Marker of Primary Hepatocellular Carcinoma (448 citations)
- Peginterferon alpha-2a (40 kDa): an advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B. (427 citations)
What are the main themes of his work throughout his whole career to date?
Shou-Dong Lee focuses on Internal medicine, Gastroenterology, Cirrhosis, Endocrinology and Surgery. His Internal medicine study deals with Immunology intersecting with Virology. His work carried out in the field of Gastroenterology brings together such families of science as Pathology, Model for End-Stage Liver Disease and Hepatitis.
His primary area of study in Cirrhosis is in the field of Hepatic encephalopathy. His Surgery study integrates concerns from other disciplines, such as Varix and Varices. His Hepatocellular carcinoma study combines topics from a wide range of disciplines, such as Cancer, Carcinoma, Proportional hazards model and Oncology.
He most often published in these fields:
- Internal medicine (86.07%)
- Gastroenterology (52.30%)
- Cirrhosis (32.89%)
What were the highlights of his more recent work (between 2010-2021)?
- Internal medicine (86.07%)
- Gastroenterology (52.30%)
- Endocrinology (31.58%)
In recent papers he was focusing on the following fields of study:
Shou-Dong Lee mainly focuses on Internal medicine, Gastroenterology, Endocrinology, Cirrhosis and Portal hypertension. His research links Surgery with Internal medicine. His Gastroenterology research integrates issues from Diabetes mellitus, Pathology, Liver cancer, Proportional hazards model and Severity of illness.
His studies in Endocrinology integrate themes in fields like Cyclooxygenase and Perfusion. His Cirrhosis course of study focuses on Hemodynamics and Streptozotocin. Shou-Dong Lee focuses mostly in the field of Portal hypertension, narrowing it down to topics relating to Cardiology and, in certain cases, Blood pressure.
Between 2010 and 2021, his most popular works were:
- Randomized Controlled Trial of Entecavir Prophylaxis for Rituximab-Associated Hepatitis B Virus Reactivation in Patients With Lymphoma and Resolved Hepatitis B (222 citations)
- Changes in postprandial gut hormones after metabolic surgery: a comparison of gastric bypass and sleeve gastrectomy. (125 citations)
- Changes in postprandial gut hormones after metabolic surgery: a comparison of gastric bypass and sleeve gastrectomy. (125 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Surgery
His primary areas of investigation include Internal medicine, Gastroenterology, Endocrinology, Hepatocellular carcinoma and Cirrhosis. His Diabetes mellitus research extends to Internal medicine, which is thematically connected. His Gastroenterology research is multidisciplinary, incorporating perspectives in Odds ratio, Liver cancer, Carcinoma, Proportional hazards model and Propensity score matching.
His Endocrinology study incorporates themes from Angiogenesis, Chronic pain, Fatty liver, Hyperalgesia and Spinal cord. His Hepatocellular carcinoma research is multidisciplinary, incorporating elements of Surgery, Hepatology, Prothrombin time and Risk factor. His research integrates issues of Superior mesenteric artery and Severity of illness in his study of Cirrhosis.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
